FDA Inspection 988682 — Biomat USA, Inc.

Biomat USA, Inc. — FEI 3022159

The FDA completed an inspection of Biomat USA, Inc. on October 12, 2016 in Boise, ID. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
October 12, 2016
Fiscal Year
2017
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Boise, ID (United States)